How many studies have been conducted on Cerebrolysin?

BiohacksAI has indexed 300 PubMed studies on Cerebrolysin, including 41 randomized controlled trials (RCTs). 52% of studies involve human subjects.

What are the main research areas for Cerebrolysin?

The primary research domains for Cerebrolysin are 🧠 Neuroprotection, ❤️ Cardiovascular, 🧠 Cognitive. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Cerebrolysin

N-PEP-12 [Supplementary Concept] Nootropic Drug derived from cerebrolysin; N-PEP-12 is much less potent than cerebrolysin but it can be administered orally Heading Mapped to: Amino Acids

300+ PubMed studies analyzed · 41 RCTs · Evidence Score: 51

Research Domains

Cerebrolysin has been studied across 17 research domains including 🧠 Neuroprotection, ❤️ Cardiovascular, 🧠 Cognitive, 🧠 Learning, 🧠 Memory. The primary research focus is 🧠 Neuroprotection with 62% of studies addressing this area.

Loading evidence profile...

This evidence profile for Cerebrolysin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.